Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 3

1.

A double-blind, randomized trial of pyridoxine versus placebo for the prevention of pegylated liposomal doxorubicin-related hand-foot syndrome in gynecologic oncology patients.

von Gruenigen V, Frasure H, Fusco N, DeBernardo R, Eldermire E, Eaton S, Waggoner S.

Cancer. 2010 Oct 15;116(20):4735-43. doi: 10.1002/cncr.25262.

2.

Prophylactic and therapeutic efficacy of pyridoxine supplements in the management of hand-foot syndrome during chemotherapy: a meta-analysis.

Jo SJ, Shin H, Jo S, Kwon O, Myung SK.

Clin Exp Dermatol. 2015 Apr;40(3):260-70. doi: 10.1111/ced.12538. Epub 2014 Dec 31. Review.

PMID:
25557587
3.

Incidence and implications of chemotherapy related hand-foot syndrome.

Nikolaou V, Syrigos K, Saif MW.

Expert Opin Drug Saf. 2016 Dec;15(12):1625-1633. Epub 2016 Oct 8. Review.

PMID:
27718746

Supplemental Content

Support Center